Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RALPH BOCCIA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1881663284
CMS profile
175674
Location
BETHESDA, MD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$433,660.62

450 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Ownership and Investment Interests

CMS also publishes Ownership and Investment Interests as a separate dataset. This site does not currently mirror it, and no ownership figure is shown on this page. This provider appears in that dataset.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Fennec Pharmaceuticals, Inc. $102,510.93 20
Pharmacosmos Therapeutics Inc. $48,193.83 37
Janssen Biotech, Inc. $37,818.71 45
SOBI, INC $37,747.26 31
BeiGene USA, Inc. $31,765.20 21
Regeneron Healthcare Solutions, Inc. $29,282.03 28
ABBVIE INC. $28,330.00 26
Karyopharm Therapeutics Inc. $19,451.00 12
Genmab U.S., Inc. $18,270.79 14
Daiichi Sankyo Inc. $13,495.96 26
Stemline Therapeutics Inc. $12,085.98 8
GENZYME CORPORATION $11,483.84 12
Rigel Pharmaceuticals, Inc. $8,743.95 14
Celgene Corporation $7,306.80 19
Amgen Inc. $5,421.72 3
Novocure Inc. $4,875.00 3
Lilly USA, LLC $4,613.46 5
Novartis Pharmaceuticals Corporation $3,563.80 16
AstraZeneca Pharmaceuticals LP $2,659.44 18
Ipsen Biopharmaceuticals, Inc $2,198.64 2
TAIHO ONCOLOGY, INC. $1,342.93 2
PFIZER INC. $362.05 13
Astellas Pharma US Inc $154.06 6
Merck Sharp & Dohme LLC $150.36 6
Eli Lilly and Company $132.26 1
Sumitomo Pharma America, Inc. $132.13 3
ACCORD HEALTHCARE, INC. $124.19 1
GlaxoSmithKline, LLC. $110.83 4
Incyte Corporation $104.94 3
Takeda Pharmaceuticals U.S.A., Inc. $100.58 4
E.R. Squibb & Sons, L.L.C. $94.33 4
Adaptive Biotechnologies Corporation $85.06 1
Eisai Inc. $75.13 3
Exelixis Inc. $72.80 3
Mirati Therapeutics, Inc. $70.76 2
ARRAY BIOPHARMA INC $64.77 3
PharmaEssentia USA Corporation $64.29 2
Tempus AI, Inc $56.93 2
PUMA BIOTECHNOLOGY, INC. $53.37 3
Blueprint Medicines Corporation $49.42 2
Kite Pharma, Inc. $49.07 2
Gilead Sciences, Inc. $49.02 2
SERVIER PHARMACEUTICALS LLC $35.62 1
Acrotech Biopharma Inc. $31.43 2
Myriad Genetic Laboratories, Inc. $31.16 2
Dendreon Pharmaceuticals LLC $25.38 1
Kyowa Kirin, Inc. $20.72 1
TerSera Therapeutics LLC $20.24 1
Janssen Pharmaceuticals, Inc $19.80 1
Apellis Pharmaceuticals, Inc. $19.65 1
Immunocore Limited $19.02 1
SpringWorks Therapeutics, Inc. $19.01 1
Alnylam Pharmaceuticals Inc. $18.90 1
Bayer Healthcare Pharmaceuticals Inc. $18.80 1
Secura Bio, Inc. $17.73 1
Deciphera Pharmaceuticals Inc. $17.33 1
CashFlow Solutions, LLC $14.47 1
RECORDATI_RARE_DISEASES_INC. $13.74 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

450 matching records · $433,660.62 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 450 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 450.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sumitomo Pharma America, Inc. $18.6512/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261148829447 CMS
Astellas Pharma US Inc $32.8012/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139447262 CMS
ABBVIE INC. $24.2912/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103340940 CMS
Janssen Biotech, Inc. $32.1512/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078714055 CMS
Fennec Pharmaceuticals, Inc. $1,015.4212/15/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186908 CMS
Apellis Pharmaceuticals, Inc. $19.6512/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261154027991 CMS
Fennec Pharmaceuticals, Inc. $149.3112/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186924 CMS
ARRAY BIOPHARMA INC $20.0612/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131237920 CMS
GENZYME CORPORATION $43.1812/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139648614 CMS
Celgene Corporation $61.3612/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121866 CMS
GlaxoSmithKline, LLC. $22.6012/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116564534 CMS
Regeneron Healthcare Solutions, Inc. $6,607.5012/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114011809 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.7212/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144953973 CMS
BeiGene USA, Inc. $2,250.0012/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120845263 CMS
Pharmacosmos Therapeutics Inc. $46.7912/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261154820281 CMS
ABBVIE INC. $46.1212/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103340938 CMS
Karyopharm Therapeutics Inc. $111.8712/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145535606 CMS
Fennec Pharmaceuticals, Inc. $385.9612/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186922 CMS
Celgene Corporation $4.2712/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101121864 CMS
PUMA BIOTECHNOLOGY, INC. $17.2012/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261113840318 CMS
ABBVIE INC. $2,550.0012/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103132229 CMS
Merck Sharp & Dohme LLC $27.8112/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141940463 CMS
PFIZER INC. $16.0212/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131429338 CMS
Acrotech Biopharma Inc. $16.6811/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147104708 CMS
Fennec Pharmaceuticals, Inc. $840.7011/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186906 CMS
Fennec Pharmaceuticals, Inc. $16.1911/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186930 CMS
Fennec Pharmaceuticals, Inc. $188.6911/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186912 CMS
ABBVIE INC. $34.5311/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103340936 CMS
Janssen Biotech, Inc. $5,625.0011/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078714063 CMS
PFIZER INC. $17.4911/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131388887 CMS
Regeneron Healthcare Solutions, Inc. $25.8411/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114011807 CMS
ABBVIE INC. $5,425.0011/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261103141851 CMS
Novocure Inc. $2,250.0011/19/2024 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118398991 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.7211/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144953971 CMS
Fennec Pharmaceuticals, Inc. $548.4911/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186904 CMS
Fennec Pharmaceuticals, Inc. $211.7111/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186918 CMS
Fennec Pharmaceuticals, Inc. $26.9111/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186928 CMS
Janssen Biotech, Inc. $5,625.0011/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078713834 CMS
Fennec Pharmaceuticals, Inc. $33,500.0011/16/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186938 CMS
Fennec Pharmaceuticals, Inc. $244.7511/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261120186916 CMS
GENZYME CORPORATION $49.7311/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139648622 CMS
GENZYME CORPORATION $1,247.0011/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139648624 CMS
PFIZER INC. $38.3211/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131388126 CMS
Alnylam Pharmaceuticals Inc. $18.9011/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261125835389 CMS
Janssen Biotech, Inc. $1,500.0011/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078713601 CMS
PFIZER INC. $26.8711/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131024576 CMS
Regeneron Healthcare Solutions, Inc. $185.1011/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114011799 CMS
Regeneron Healthcare Solutions, Inc. $70.7111/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114011801 CMS
Regeneron Healthcare Solutions, Inc. $10.5111/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114011803 CMS
Regeneron Healthcare Solutions, Inc. $36.7711/11/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114011805 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $707,458.24 649
PY2020 $452,016.98 405
PY2021 $393,668.10 454
PY2022 $493,041.79 506
PY2023 $415,808.04 493
PY2024 $433,660.62 450
PY2025 $244,074.29 326

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
RALPH BOCCIA, NPI 1881663284. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1881663284.
APA 7
IndustryPayments. (2026). RALPH BOCCIA, NPI 1881663284 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1881663284
Bluebook
RALPH BOCCIA, NPI 1881663284, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1881663284.

Source: Centers for Medicare & Medicaid Services, Open Payments.